MSCL:TSE
Satellos Bioscience Inc
CA$13.45
arrow_downward
-3.45%(-0.48) 1D
Sep 11, 3:33:16 PM GMT-4 · CAD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MSCL...
Open
CA$13.99
High
CA$14.16
Low
CA$13.45
Mkt. cap
285.36M
Avg. vol.
12.56K
Volume
4.10K
52-wk high
CA$18.98
52-wk low
CA$7.32
EPS
-CA$2.74
Beta
1.15
Shares outstanding
21.22M
No. of employees
20
Open
CA$13.99
High
CA$14.16
Low
CA$13.45
Mkt. cap
285.36M
Avg. vol.
12.56K
Volume
4.10K
52-wk high
CA$18.98
52-wk low
CA$7.32
EPS
-CA$2.74
Beta
1.15
Shares outstanding
21.22M
No. of employees
20
News stories
From web sources and news partners
Investing.com
·
1 day ago
Satellos at Cantor healthcare conference: pipeline nears key data
Investing.com
·
2 days ago
Satellos assigns INN forazapadin to DMD drug candidate
TipRanks
·
2 days ago
Satellos Bioscience Secures INN ‘Forazapadin’ for Lead Duchenne Drug as Phase 2 Programs Advance
Stock Titan
·
2 days ago
A muscle disease treatment candidate gets a new global name: forazapadin
About Satellos Bioscience Inc
CEO-
Employees20
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitesatellos.com